Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,967,227
  • Shares Outstanding, K 29,058
  • Annual Sales, $ 166,030 K
  • Annual Income, $ -84,600 K
  • EBIT $ -54 M
  • EBITDA $ -46 M
  • 60-Month Beta 0.92
  • Price/Sales 10.41
  • Price/Cash Flow N/A
  • Price/Book 114.43

Options Overview Details

View History
  • Implied Volatility 59.02% (+1.79%)
  • Historical Volatility 52.41%
  • IV Percentile 19%
  • IV Rank 14.59%
  • IV High 123.47% on 04/08/25
  • IV Low 48.01% on 06/12/25
  • Expected Move (DTE 29) 7.61 (11.13%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 150
  • Volume Avg (30-Day) 993
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 40,369
  • Open Int (30-Day) 40,472
  • Expected Range 60.75 to 75.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.27
  • Prior Year -0.98
  • Growth Rate Est. (year over year) +77.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.29 +8.64%
on 01/20/26
76.76 -10.42%
on 12/23/25
-7.85 (-10.25%)
since 12/22/25
3-Month
47.00 +46.30%
on 11/03/25
78.24 -12.12%
on 12/17/25
+18.91 (+37.93%)
since 10/22/25
52-Week
26.56 +158.89%
on 04/09/25
78.24 -12.12%
on 12/17/25
+32.53 (+89.79%)
since 01/22/25

Most Recent Stories

More News
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Revenue for the quarter ended December 31, 2025 is expected to be between $64.0 million and $65.0 million, including between $17.0 million and $17.5 million from Motiva sales in the United States. ...

ESTA : 69.33 (+2.41%)
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 69.33 (+2.41%)
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 69.33 (+2.41%)
Establishment Labs to Present at Jefferies London Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 69.33 (+2.41%)
Establishment Labs Reports Third Quarter 2025 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 69.33 (+2.41%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 69.33 (+2.41%)
Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.Elevate...

ESTA : 69.33 (+2.41%)
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

ESTA : 69.33 (+2.41%)
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced...

ESTA : 69.33 (+2.41%)
Citi Sticks to Its Hold Rating for Establishment Labs Holdings (ESTA)

In a report released on October 3, Joanne Wuensch from Citi maintained a Hold rating on Establishment Labs Holdings, with a price target of $43.00. The company’s shares closed yesterday at $39.33.Elevate...

ESTA : 69.33 (+2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its...

See More

Key Turning Points

3rd Resistance Point 73.59
2nd Resistance Point 71.21
1st Resistance Point 69.45
Last Price 69.33
1st Support Level 65.32
2nd Support Level 62.94
3rd Support Level 61.18

See More

52-Week High 78.24
Last Price 69.33
Fibonacci 61.8% 58.50
Fibonacci 50% 52.40
Fibonacci 38.2% 46.30
52-Week Low 26.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar